MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests experimental drug for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first time a new cancer drug called ifinatamab deruxtecan (I-DXd) is being tested in people. The study aims to find a safe and effective dose for patients with advanced solid tumors that have not responded to standard treatments. Researchers will monitor participants …
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cancer drug seeks to tame tough tumors
Disease control Recruiting nowThis study is testing a new drug called FH-006 for people with advanced solid tumors that have grown despite standard treatments. The main goals are to find a safe and effective dose and to see how well the drug works at controlling the cancer. It is for adults whose cancer has r…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human test of new Tumor-Injected therapy for tough cancers
Disease control Recruiting nowThis is an early-stage safety study for a new drug called ANK-101, which is injected directly into tumors. It aims to find a safe dose for people with advanced solid cancers that have stopped responding to standard treatments. The study will test the drug alone in different types…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Ankyra Therapeutics, Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Doctors test 'Match-Making' drugs for tough cancers
Disease control Recruiting nowThis trial is testing whether personalized cancer drugs, chosen based on the specific genetic changes found in a patient's tumor, can help control advanced cancers that have stopped responding to standard treatments. It will enroll about 455 adults with various advanced solid tum…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for kids with tough cancers: Four-Drug combo trial opens
Disease control Recruiting nowThis study is testing a new combination of four medicines for children and young adults (under 30) whose solid tumors have come back or haven't responded to standard treatments. The first part checks if the drug mix is safe and finds the right dose. The second part sees how well …
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New scan aims to see inside tumors during treatment
Knowledge-focused Recruiting nowThis early-stage study is testing a new imaging agent, given as an injection, to see if it can safely and effectively show what's happening inside solid tumors. Researchers want to see if special PET scans using this tracer can detect changes in tumors after patients receive immu…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: GE Healthcare • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Massive canadian cancer study hunts clues in rare genes
Knowledge-focused Recruiting nowThis study aims to gather real-world information from 5,500 Canadian adults with cancer who have uncommon genetic changes in their tumors. It will track their health journeys, treatments, and quality of life to understand how different therapies work for these specific genetic pr…
Matched conditions: MALIGNANT SOLID TUMOR
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC